ARL Bio Pharma provides analytical and microbiological testing for compounding pharmacies, outsourcing facilities, and health-system pharmacies. Our laboratory partners with industry suppliers bringing excellence to the compounding industry.
- Potency Determination
- BUD and Stability Studies
- Microbial Identification
- Microbial Enumeration Tests
- Tests for Specified Organisms
- Antimicrobial Effectiveness Testing
- Particulate Matter by Light Obscuration
- Particulate Matter by Microscopy
Raw Material Services
ARL Bio Pharma qualifies drug substances, excipients, and drug products to meet pharmacopeia specifications.
- Identification by IR
- Identification by UV
- Specific Gravity
- Water – Methods 1a, 1b, 2 and 3
- Residual Solvents
- Melting Point / Melting Range
- Loss on Drying
- Residue on Ignition
- Assay – HPLC, UV, Titration
- Heavy Metals
- USP / NF (United States Pharmacopeia) testing
- EP (European Pharmacopeia) testing
- JP (Japanese Pharmacopeia) testing
ARL provides full laboratory services for pharmaceutical and biotechnology companies. Laboratory services include testing for New Drug Application (NDA), Abbreviated New Drug Application (ANDA), medical devices (510K) and over-the-counter products.
- Stability Studies
- Compatibility Studies
- Raw Material Testing
- Dissolution Testing
- Microbial Identification
- Bioequivalence Studies
- Pre-clinical and Clinical Analytical Testing
ARL Bio Pharma provides comprehensive services to solve challenging drug investigations. These services are unique and specialized in pharmaceutical, toxicological, regulatory support, and research and development.
- Drug Diversion Testing
- Confirm identity of drug in a suspect or biological sample
- Product Contamination
Dr. Thomas C. Kupiec, CEO and President
Dr. Thomas Kupiec is the CEO of ARL Bio Pharma (ARL) and DNA Solutions Inc. Dr. Kupiec received his Ph.D in Pharmaceutical Sciences from the University of Oklahoma Health Sciences Center College of Pharmacy. He currently serves as a graduate faculty member at the OU Health Sciences Center and has held teaching appointments at several universities. He has published numerous articles and abstracts in a variety of fields including pharmaceutical sciences, forensic sciences and pharmacogenomics. Dr. Kupiec is often requested as a speaker at national pharmaceutical conferences and has spoken at ASHP, IACP, ACA and for state pharmaceutical associations.
Dr. Kupiec’s vision of entrepreneurial research is manifested by his responsibilities at DNA Solutions and ARL, which include supplying technical expertise and business development in the pharmaceutical and forensic fields. Additionally, Dr. Kupiec offers consultation services for a variety of pharmacy related fields as well as expert witness testimony in the fields of forensic toxicology and pharmaceutical sciences. He has testified in over a hundred cases, both civil and criminal, in federal, state and municipal courts.
His professional experience includes various appointments at Northwest Toxicology Inc. (NWT), the Federal Aviation Administration (FAA) and the Oklahoma City Police Department. Dr. Kupiec is affiliated with numerous professional organizations, including the American Academy of Forensic Sciences, American Association of Pharmaceutical Scientists, American Society of Health-System Pharmacists, the Society of Forensic Toxicologists, and Sigma Xi, The Scientific Research Society.
David Baer, CFO
David Baer is the Chief Financial Officer for ARL Bio Pharma. Baer is a seasoned financial manager and innovator with over 25 years working at public and private companies. At ARL Bio Pharma, Baer oversees all financial, accounting and administration aspects, as well as the information technology department, and he brings unique expertise to his role as a member of the executive group.
As a former partner and owner in his own accounting practice and in various accounting leadership roles throughout his career, Baer has achieved many years of payroll, financial and cash management experience which has enabled him to provide stability and a good foundation for future growth at ARL Bio Pharma.
Baer is a CPA and graduate of the University of Louisiana with a BBA in Accounting. He is also a graduate of the School of Mortgage Banking from Northwestern University in Chicago.
Elena Chitsey, Controller
Elena Chitsey serves as the Controller for ARL Bio Pharma. Elena was appointed as Controller by the CEO, Dr. Thomas Kupiec in March of 2012.
As Controller for ARL Bio Pharma, Elena provides oversight to and is responsible for all accounting functions within the company.
Elena has been with ARL Bio Pharma for over 17 years and during this time she has worked in various positions with increasing responsibility. Elena is dedicated in her pursuit to develop and maintain a system of accounting policies and procedures, internal accounting controls, and manage the operations of the Accounting Department.
Elena graduated with a Bachelor of Science from the University of Central Oklahoma. She is a Certified Public Accountant in the State of Oklahoma and is a member of the Oklahoma Accountancy Board.
Dr. Nicole Vu, Scientific Director
Dr. Nicole Vu is the Scientific Director for ARL Bio Pharma and it's sister company DNA Solutions. She is focused on ensuring the science and technology that both companies utilize is of the highest quality. Before joining the team in 2004, Dr. Vu spent over a decade with the Federal Aviation Administration in the Forensic Toxicology and Bioaeronautical Sciences Research Laboratory where she served as a Research Chemist and later as Team Leader to conduct research in Aviation Toxicology and Toxicogenomics.
Her professional experiences also includes appointments as Specialist in Immunohematology at OU Medical Center, and adjunct professor in Forensic Serology at the University of Central Oklahoma.
Dr. Vu is affiliated with various professional organizations including American Association of Pharmaceutical Scientists, and is an active member of Institutional Biosafety Committee at OU Health Sciences Center.
Dr. Vu educational credentials include a bachelor's degree in Biology and Chemistry from The University of the Ozarks, a bachelor's degree in Medical Technology from Arkansas State University and a bachelor's degree in Pharmacy from The University of Oklahoma, Health Sciences Center. Dr. Vu has also received a Ph.D. in Pharmaceutical Sciences from The College of Pharmacy at the University of Oklahoma, Health Sciences Center. She currently serves as a graduate faculty member at the OU Health Sciences Center and has adjunct teaching appointments at OU College of Pharmacy.
Vince Bobin, Laboratory Director
Vince Bobin is the Associate Laboratory Director for ARL Bio Pharma and has overall responsibility for the Chemistry, Microbiology, Analytical and Projects/R&D departments. He received his BS in Biochemistry from the State University of New York at Geneseo.
Vince’s previous work history includes quality control testing for Procter and Gamble, and most recently, 10+ years of analytical research and development for Pfizer. He has a strong GMP background and experience with regulatory filings including IND’s, NDA/MAA’s.
Tommy Means, Quality Director
Tommy Means is the Quality Manager for ARL Bio Pharma (ARL) and DNA Solutions Inc. He is focused on ensuring that Quality Systems for both companies are functional and operational. This includes ISO, FDA, USP, DEA, EPA & AABB compliance and regulations.
Tommy’s professional background includes work in Gas Chromatography, Project Management, Quality Control / Quality Assurance and Vendor Auditing. Tommy is a member of the American Society of Quality, The Institute of Validation Technology & American Association of Blood Banks.
Prior to joining ARL and DNA, Tommy was part of the Research and Development team of Brown and Williamson Tobacco Company. Tommy received his Bachelor’s degree in Chemistry from Northwestern Oklahoma State University.
Brian Kelley, Director of Business Development
Brian Kelley is the Director of Business Development for ARL Bio Pharma. He graduated from Oklahoma State University with a Bachelor’s Degree in Biology.
Brian’s professional background includes 10 years of research, development, and project management in the biotech industry at Genzyme in Oklahoma City. His previous experience includes analytic chemistry, tissue culture, and pre-clinical pharmacokinetic and pharmacodynamics studies.
Bryan Sagebiel, IT Director
Bryan Sagebiel is the Information Technology Director for ARL BioPharma. Bryan is responsible for the overall planning, organizing, and execution of all IT functions throughout ARL. His 27-year professional IT career includes consulting, software development, oil and gas, education, construction, law, residential appraisals, and banking.
Before joining the team in 2016, Bryan owned a consulting service, which provided specialized consulting services to Geology Managers, Geoscientists, Data Managers and Information Technology on application performance, data governance, and best practices for Geographix and other Geoscience applications serving customers across Oklahoma, Texas, and Pennsylvania.
His professional experience also includes responsibility as Chief Solutions Architect for EnergyIQ, management and leadership positions in Information Technology, and Geosciences for Chesapeake Energy Corporation. His management guidance led technical teams to build corporate IT infrastructure systems for Chesapeake’s extreme growth years.
Bryan holds a bachelor’s degree in Computer Information Systems from Tarleton State University and is a native of Fredericksburg, TX.
- Potency Price List.pdf (1.2 MB)
- Sample Submission Form (220.85 KB)
- Sample Submission Guidelines (100.02 KB)
- Quality Agreement for non-cGMP Testing Services (66.94 KB)
- Quality Agreement for cGMP Testing Services (68.4 KB)
- Chain Of Custody (29.47 KB)
- Terms and Conditions for testing 2017 ARL Routine Testing (228.02 KB)
- Terms and Conditions for studies 2017 - Word (255.61 KB)
- Terms and Conditions for Studies 2017 - PDF (71.21 KB)
- Stability Study Questionnaire (528.59 KB)
- Credit Card Authorization Form (207.5 KB)
- Submitting for Sterility Testing (129.21 KB)
- Microbial Identification Sample Submission Guidelines (86.75 KB)